Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. August 2012 11:05 ET | Quelle: Novavax, Inc.

NOVAVAX to Present at the 2012 Wedbush Life Sciences Conference

ROCKVILLE, Md., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
03. August 2012 08:00 ET | Quelle: Novavax, Inc.

NOVAVAX Reports Second Quarter 2012 Financial Results

ROCKVILLE, Md., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2012. Second Quarter 2012 and...
27. Juli 2012 09:00 ET | Quelle: Novavax, Inc.

NOVAVAX to Report Second Quarter 2012 Financial Results on August 3, 2012

ROCKVILLE, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 second-quarter financial results on Friday, August 3, 2012, before the U.S....
24. Juli 2012 16:05 ET | Quelle: Novavax, Inc.

NOVAVAX Provides Update on Influenza Programs

Primary Endpoints Achieved in Phase II Seasonal Influenza Trial Two H5N1 Pandemic Influenza Trials Fully Enrolled ROCKVILLE, Md., July 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....
18. Juli 2012 08:00 ET | Quelle: Novavax, Inc.

NOVAVAX and PATH Announce Partnership on RSV Vaccine

Novavax initially awarded approximately $2 million by PATH Potential for future PATH funding of 50% of external costs to develop maternal RSV vaccine available for low-resource...
16. Juli 2012 08:00 ET | Quelle: Novavax, Inc.

NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India

ROCKVILLE, Md., July 16, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), today announced...
05. Juli 2012 09:02 ET | Quelle: Novavax, Inc.

NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines

ROCKVILLE, Md., July 5, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) reported this week that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, reviewed recent...
27. Juni 2012 08:00 ET | Quelle: Novavax, Inc.

Novavax to Review RSV Program at New International Conference on Modern Vaccines

ROCKVILLE, Md., June 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, will make a plenary...
04. Juni 2012 08:00 ET | Quelle: Novavax, Inc.

NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference

ROCKVILLE, Md., June 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
21. Mai 2012 12:58 ET | Quelle: Novavax, Inc.

NOVAVAX, Inc. Announces $12 Million Equity Offering

ROCKVILLE, Md., May 21, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that on Friday, May 18, 2012, it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund,...

Vorherige Seite